Myeloma 2016: Panel discussion on the status of genomics
Chng Wee Joo et al.
Factors to consider in frontline and relapsed CLL before treatment
Discussion of the two biologies of DLBCL - the GCB and ABC subtype and potential targeted therapies
The aims of the Genomics England CLL pilot
How the management of CLL is evolving